Most Hypogonadal Men with Type 2 Diabetes Mellitus (T2DM) Achieve HbA1c Targets when Treated with Testosterone Undecanoate (TU) Injections for Up to 12 Years

被引：0

|

作者：

Saad, Farid

Doros, Gheorghe

Yassin, Aksam

机构：

来源：

DIABETES | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1144-P

引用

收藏

页码：A305 / A305

页数：1

相关论文

共 50 条

[21] Effect of Iron Deficiency Anaemia on HbA1c levels in a cohort of patients with Type 2 diabetes mellitus (T2DM) in Sri Lanka
Kariyawasan, Chitranga
Dissanayaka, Champika
Balasuriya, Thushara
Ranatunga, Charith
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 184 - 185
[22] Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2021, 70
[23] Correlation of HbA1c with daily fluctuation of blood glucose in insulin treated patients with Type 2 diabetes mellitus (T2 DM).
Kalyvinos, A
Bakatselos, S
Tsapas, B
Papadopoulos, G
Sakallerou, A
Pitsava, E
Hatzileftheriou, H
DIABETOLOGIA, 2003, 46 : A240 - A240
[24] Perception, HbA1c and the Quality of Life of Diabetes Mellitus (T2DM) Patients at RSUD Abdul Azis Singkawang
Faridah, Imaniar Noor
Masyithah, Nurul
Perwitasari, Dyah Aryani
ADVANCED SCIENCE LETTERS, 2017, 23 (12) : 12464 - 12468
[25] Sustained Improvement of Obesity in Hypogonadal Men with Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)-Real-Life Evidence from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2018, 67
[26] REMISSION OF TYPE 2 DIABETES (T2DM) IN 33.6% (51 OF 152) HYPOGONADAL MEN RECEIVING LONG-TERM TESTOSTERONE THERAPY FOR UP TO 12 YEARS IN A REAL-LIFE REGISTRY STUDY
Haider, K. S.
Haider, A.
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S104 - S104
[27] Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2019, 68
[28] Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Margaret Bannister
Jenny Berlanga
Diabetes Therapy, 2016, 7 : 387 - 399
[29] Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Bannister, Margaret
Berlanga, Jenny
DIABETES THERAPY, 2016, 7 (03) : 387 - 399
[30] TESTOSTERONE TREATMENT LEADS TO SUSTAINED IMPROVEMENTS OF ERECTILE FUNCTION UP TO 11 YEARS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM): REAL-LIFE DATA FROM AN OBSERVATIONAL REGISTRY STUDY
Saad, F.
Yassin, A.
JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 403 - 403

← 1 2 3 4 5 →